Ricky Trigg

Senior Scientist
GlaxoSmithKline
Ricky Trigg
Ricky obtained his PhD in cancer genomics from the University of Leicester, before joining the University of Cambridge as a postdoc. His postdoctoral work focused on identification of mechanisms of resistance to anti-cancer compounds in paediatric malignancies. In this project, he employed genome-wide CRISPR knockout and activation screens to identify novel drug targets and devised novel combination treatment strategies to prevent emergence of drug resistance in mouse cancer models. Ricky recently joined the Functional Genomics team at GSK and is conducting genome-wide CRISPR knockout screens in primary immune cells for target identification. He is also developing tools to enable CRISPR activation studies in primary cells.

Sessions

No data was found

Live Webinar

Higher Quality Nucleic Acid Extraction from FFPE Tissue & Other Challenging Samples Using the Ionicâ„¢ Purification System

hosted by Klint Rose, Chief Scientific Officer, Purigen Biosystems

Wednesday 27th May
16:00 BST